Global Women's Health Diagnostics Market to Cross USD 36.6 Bn by 2021, Predicts M&M in Its Report Recently Uploaded at MarketPublishers.com
14 Dec 2017 • by Natalie Aster
LONDON – The world’s market for women’s health diagnostics is currently on the rise. The market is expected to grow further and to exceed USD 36.6 billion by 2021, posting a healthy CAGR of almost 8% in the next 5 years.
Growth in the women’s health diagnostics market is predicted to be encouraged by such favourable factors as high prevalence of infectious diseases in women, escalating incidence of chronic and lifestyle-related disorders, positive government initiatives and also rising awareness of fertility testing in women. Additionally, expanding adoption of POC diagnostic testing and escalating number of diagnostic and imaging centers worldwide are also amid top market growth drivers. But, further market growth could be hampered by lack of trained laboratory technicians and high cost of diagnostic solutions.
In 2015, spurred by rising incidence of breast cancer and also enhancing awareness of advanced breast cancer diagnostic techniques, the breast cancer testing product segment dominated the total women’s health diagnostics market.
Globally, North America is the largest regional market for women’s health diagnostics owing to increasing incidence of cancer amid local female population and presence of a great number of influential players and their efforts to expand presence in the region. The North American women’s health diagnostics market is likely to continue following an upward trend and maintain its leading position through 2021.
Siemens AG, Quest Diagnostics, Hologic, F. Hoffmann-La Roche AG, PerkinElmer, Alere, GE Healthcare, Becton, Dickinson and Company (BD), Abbott Laboratories, bioMérieux SA and Koninklijke Philips N.V. are amid are the major participants in the marketplace.
Topical research publication by M&M, “Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021”, gives an all-round analysis of the world’s market for women’s health diagnostics.
This insightful research report delves deep into the women’s health diagnostics market scenario, providing reliable info on all segments (basing on application, end users and regions), upcoming and ongoing trends, research and development activities, the recent product launches and other important aspects. Moreover, the report provides data on the market shares, growth rates, products developments, distribution channels, leading players and competitive landscape. It also carefully examines the market dynamics, touches upon the market growth drivers, restraints, opportunities and challenges. Additionally, comprehensive future forecasts for the world’s women’s health diagnostics market up till 2021 are offered in the report.
Other latest research reports by M&M are available in its catalogue at MarketPublishers.com.